Pediatric Neuromuscular Disorders

ZINCARE

J. Wilmshurst

Duchenne Muscular Dystrophy and Gene Therapy: What's On the Horizon?

The France Foundation

H. Abdel-Hamid, A. Veerapandiyan

Approach to a Child with Delayed Walking

UCSF School of Medicine

Y. Mitsuya

Newborn Screening Programs: Development, Implementation, and the Roa…

Muscular Dystrophy Association

M. Caggana

Genetic Testing and Counseling for Neuromuscular Diseases

Muscular Dystrophy Association

L. Gutmann, S. Feely

Pediatric Indications for Botulinum Toxin

UCSF School of Medicine

K. Sigford

General Movement Assessment (GMA) and Hammersmith Infant Neurologica…

University of Utah Neurology

S. Moss

The ALS Exposome: Where Science Meets Patient Care

ALS ONE

E. Feldman

Updates in Pompe Disease

Muscular Dystrophy Association

B. K. Burton

Advances in the Management of Small Fiber Peripheral Neuropathy

Lawrence Zeidman

Complement Inhibitors in Myasthenia Gravis

Jean-Raphael Schneider

Modifying the Placebo Effects in Clinical Trials

Aziz Shaibani

Lambert-Eaton Myasthenic Syndrome (LEMS) - Clinical Pearls

For-Shing Lui

HIV and the Nervous System - 2024 Updates

ZINCARE

F. Mutete

Nerve Conduction Pitfalls

Bassam A. Bassam

Periodic Paralysis: Pathogenesis and Possibilities for Therapy

University of Utah Neurology

S. Cannon

Sonographic Needle Guidance for Carpal Tunnel Injections

Elena Shanina

Statin Myopathy

ACR Convergence 2022 Coverage

L. Christopher-Stine

The Diagnostic Utility of TMS in ALS

P Menon